BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blanc-Durand F, Genestie C, Galende EY, Gouy S, Morice P, Pautier P, Maulard A, Mesnage S, Le Formal A, Brizais C, Richardson M, Leary A. Distribution of novel immune-checkpoint targets in ovarian cancer tumor microenvironment: A dynamic landscape. Gynecol Oncol 2021;160:279-84. [PMID: 33162175 DOI: 10.1016/j.ygyno.2020.09.045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Vanguri R, Benhamida J, Young JH, Li Y, Zivanovic O, Chi D, Snyder A, Hollmann TJ, Mager KL. Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer. Gynecologic Oncology Reports 2022. [DOI: 10.1016/j.gore.2022.100926] [Reference Citation Analysis]
2 Chardin L, Leary A. Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1. Front Oncol 2021;11:795547. [PMID: 34966689 DOI: 10.3389/fonc.2021.795547] [Reference Citation Analysis]
3 Spirina L, Avgustinovich A, Afanas'ev S, Volkov M, Dobrodeev A, Cheremisina O, Kostromitsky D. PD-L1 Status in Gastric Cancers, Association with the Transcriptional, Growth Factors, AKT/mTOR Components Change, and Autophagy Initiation. Int J Mol Sci 2021;22:11176. [PMID: 34681840 DOI: 10.3390/ijms222011176] [Reference Citation Analysis]
4 Schoutrop E, Moyano-Galceran L, Lheureux S, Mattsson J, Lehti K, Dahlstrand H, Magalhaes I. Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment. Semin Cancer Biol 2022:S1044-579X(22)00083-9. [PMID: 35395389 DOI: 10.1016/j.semcancer.2022.03.027] [Reference Citation Analysis]
5 Liu J, Wang Y, Yuan S, Wei J, Bai J. Construction of an Immune Cell Infiltration Score to Evaluate the Prognosis and Therapeutic Efficacy of Ovarian Cancer Patients. Front Immunol 2021;12:751594. [PMID: 34745124 DOI: 10.3389/fimmu.2021.751594] [Reference Citation Analysis]
6 Ye X, An L, Wang X, Zhang C, Huang W, Sun C, Li R, Ma H, Wang H, Gao M. ALOX5AP Predicts Poor Prognosis by Enhancing M2 Macrophages Polarization and Immunosuppression in Serous Ovarian Cancer Microenvironment. Front Oncol 2021;11:675104. [PMID: 34094977 DOI: 10.3389/fonc.2021.675104] [Reference Citation Analysis]